| 607748 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Phenolamides: Plant specialized metabolites with a wide range of promising pharmacological and health-promoting interests |
2020-11-01 |
10.1016/j.biopha.2020.110762 |
Roumani Marwa, Duval Raphaël E., Ropars Armelle, Risler Arnaud, Robin Christophe, Larbat Romain |
| 607747 |
BMJ OPEN |
Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016–2018: an interrupted time series study in Shaanxi |
2020-11-01 |
10.1136/bmjopen-2020-037034 |
Yan Kangkang, Yang Caijun, Zhang Hongli, Ye Dan, Liu Shengyuan, Chang Jie, Jiang Minghuan, Zhao Mingyue, Fang Yu |
| 607746 |
BMJ OPEN |
Application of the theory of regulatory fit to promote adherence to evidence-based breast cancer screening recommendations: experimental versus longitudinal evidence |
2020-11-01 |
10.1136/bmjopen-2020-037748 |
Petrocchi Serena, Ludolph Ramona, Labrie Nanon H M, Schulz Peter |
| 607745 |
CLINICAL ENDOSCOPY |
Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions |
2020-11-01 |
10.5946/ce.2020.165 |
Kamani, Lubna, Arshad, Muhammad |
| 607744 |
ONCOTARGETS AND THERAPY |
Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study |
2020-11-01 |
10.2147/ott.s277532 |
Geng Qian, Shen Hua, Zhu Wenyu, Lu Yingzhi, Wang Mengjie, Jiang Hua, Li Dongqing |
| 607743 |
CANCER MANAGEMENT AND RESEARCH |
Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma |
2020-11-01 |
10.2147/cmar.s273244 |
Hu Xiao-Ying, Liu Dong-Wei, Qiao Ying-Jin, Zheng Xuan, Duan Jia-Yu, Pan Shao-Kang, Liu Zhang-Suo |
| 607742 |
WORLD NEUROSURGERY |
Letter to the Editor: “Beyond Containment: Tracking the Impact of Coronavirus Disease 2019 (COVID-19) on Neurosurgery Services in Iraq” |
2020-11-01 |
10.1016/j.wneu.2020.08.060 |
Hoz Samer S., Al-Sharshahi Zahraa F., Dolachee Ali A., Matti Wamedh E. |
| 607741 |
NEURO-ONCOLOGY |
EPCO-10. CHANGES IN ALTERNATIVE SPLICING AND ASSOCIATED NEOANTIGENS DUE TO THERAPY | EPCO-10. CHANGES IN ALTERNATIVE SPLICING AND ASSOCIATED NEOANTIGENS DUE TO THERAPY |
2020-11-01 |
10.1093/neuonc/noaa215.289 |
Wang Lin, Shamardani Karin, Babikir Husam, Catalan Francisca, Nejo Takahide, Chang Susan, Philips Joanna, Okada Hideho, Diaz Aaron |
| 607740 |
NEURO-ONCOLOGY |
CSIG-14. COMBINING THE GLIOBLASTOMA CELL MEMBRANE-PERMEABILIZING EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) WITH WITHAFERIN A (AND OTHER) CHEMOTHERAPY | CSIG-14. COMBINING THE GLIOBLASTOMA CELL MEMBRANE-PERMEABILIZING EFFECT OF TUMOR TREATING FIELDS (TTFI |
2020-11-01 |
10.1093/neuonc/noaa215.126 |
Chang Edwin, Patel Chirag, Young Caroline, Flores Thomas, Zeng Yi, Joubert Lydia, Arami Hamed, Natarajan Arutselvan, Sinclair Robert, Gambhir Sanjiv |
| 607739 |
NEURO-ONCOLOGY |
CTNI-20. PCV CHEMOTHERAPY ALONE IS ASSOCIATED WITH BETTER CLINICAL COURSE IN OLIGODENDROGLIOMA WHO GRADE II | CTNI-20. PCV CHEMOTHERAPY ALONE IS ASSOCIATED WITH BETTER CLINICAL COURSE IN OLIGODENDROGLIOMA WHO GRADE II |
2020-11-01 |
10.1093/neuonc/noaa215.187 |
Weller Jonathan, Katzendobler Sophie, Karschnia Philipp, Lietke Stefanie, Egensperger Rupert, Thon Niklas, Weller Michael, Kreth Friedrich-Wilhelm, Suchorska Bogdana, Tonn Joerg-Christian |
